NIP
Nicholas Investment Partners’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,931
| Closed | -$404K | – | 240 |
|
|
2024
Q2 | $404K | Buy |
+2,931
| New | +$404K | 0.04% | 191 |
|
|
2020
Q2 | – | Sell |
-27,668
| Closed | -$2.4M | – | 190 |
|
|
2020
Q1 | $2.4M | Sell |
27,668
-1,742
| -6% | -$151K | 0.47% | 85 |
|
|
2019
Q4 | $3.16M | Sell |
29,410
-10,521
| -26% | -$1.13M | 0.33% | 100 |
|
|
2019
Q3 | $3.6M | Buy |
39,931
+5,941
| +17% | +$535K | 0.3% | 128 |
|
|
2019
Q2 | $2.87M | Buy |
33,990
+3,644
| +12% | +$308K | 0.26% | 126 |
|
|
2019
Q1 | $2.67M | Buy |
30,346
+7,107
| +31% | +$626K | 0.24% | 143 |
|
|
2018
Q4 | $1.66M | Buy |
23,239
+1,149
| +5% | +$82K | 0.18% | 179 |
|
|
2018
Q3 | $2.72M | Sell |
22,090
-1,211
| -5% | -$149K | 0.22% | 168 |
|
|
2018
Q2 | $2.29M | Buy |
23,301
+2,313
| +11% | +$227K | 0.16% | 178 |
|
|
2018
Q1 | $1.74M | Buy |
+20,988
| New | +$1.74M | 0.12% | 198 |
|
|
2016
Q4 | – | Sell |
-168,624
| Closed | -$8.54M | – | 322 |
|
|
2016
Q3 | $8.54M | Buy |
168,624
+9,202
| +6% | +$466K | 0.57% | 30 |
|
|
2016
Q2 | $7.25M | Buy |
159,422
+93,687
| +143% | +$4.26M | 0.5% | 44 |
|
|
2016
Q1 | $2.6M | Sell |
65,735
-12,537
| -16% | -$496K | 0.19% | 207 |
|
|
2015
Q4 | $4.43M | Buy |
+78,272
| New | +$4.43M | 0.31% | 129 |
|